Plasma Free Fatty Acids and Risk of Heart FailureClinical Perspective

Slides:



Advertisements
Similar presentations
Circulating Long-Chain ω-3 Fatty Acids and Incidence of Congestive Heart Failure in Older Adults: The Cardiovascular Health Study Funded by: National Institutes.
Advertisements

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.
Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.
Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity by Dariush Mozaffarian Circulation Volume 133(2): January 12, 2016.
Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?Clinical Perspective by Peter J. Schwartz,
Structure of Cis and Trans Fatty Acids
Copyright © 2005 American Medical Association. All rights reserved.
by Hiroyuki Morita, and Issei Komuro
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
EMPA-REG OUTCOME: The Endocrinologist's Point of View
EMPA-REG OUTCOME: The Endocrinologist's Point of View
by Adam J. Singer, Robert H
Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyCLINICAL PERSPECTIVE by A. Dénise.
Circ Cardiovasc Interv
Forecasting the Impact of Heart Failure in the United States
Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,
by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D
B-Type Natriuretic Peptide Testing and the Accuracy of Heart Failure Diagnosis in the Emergency DepartmentCLINICAL PERSPECTIVE by Amaali Lokuge, Louisa.
Role of Right Ventricle and Dynamic Pulmonary Hypertension on Determining ΔVO2/ΔWork Rate FlatteningCLINICAL PERSPECTIVE by Francesco Bandera, Greta Generati,
Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart FailureClinical Perspective by Satoshi.
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
Arterioscler Thromb Vasc Biol
Arterioscler Thromb Vasc Biol
Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.
Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,
Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee,
Association of Rare Loss-Of-Function Alleles in HAL, Serum HistidineCLINICAL PERSPECTIVE by Bing Yu, Alexander H. Li, Donna Muzny, Narayanan Veeraraghavan,
Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing.
Circ Cardiovasc Qual Outcomes
Association Between Mycoplasma Pneumonia and Increased Risk of Ischemic Stroke by Chia-Hung Chiang, Chin-Chou Huang, Wan-Leong Chan, Yu-Chun Chen, Tzeng-Ji.
Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.
Site Selection and Performance in Clinical Trials
Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure PatientsClinical Perspective by Ann M. Swank, John Horton,
Circ Cardiovasc Qual Outcomes
Circ Cardiovasc Interv
Circ Cardiovasc Qual Outcomes
by Thomas Monks, Martin Pitt, Ken Stein, and Martin James
Relative Distributions
Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,
Contribution of Stroke to the Cochrane Stroke Group Trials Register
Circ Arrhythm Electrophysiol
by Johan Denollet, Angélique A. Schiffer, and Viola Spek
Reflux Esophagitis and the Risk of Stroke in Young Adults
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,
by Parag C. Patel, Colby R. Ayers, Sabina A
Risk of Heart Failure Among Postmenopausal WomenCLINICAL PERSPECTIVE
Mathematical representation of Bayes theorem.
Arterial Stiffness, Central Pressures, and Incident Hospitalized Heart Failure in the Chronic Renal Insufficiency Cohort StudyCLINICAL PERSPECTIVE by Julio.
Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.
Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,
Resting Ventricular–Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE by Selma F. Mohammed,
Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening by Jonathan M. Sorof, Jennifer Turner,
Circ Cardiovasc Interv
Volume 10, Issue 10, Pages (October 2013)
EMPA-REG OUTCOME: The Endocrinologist's Point of View
Volume 10, Issue 10, Pages (October 2013)
Volume 8, Issue 2, Pages (February 2011)
Masashi Maeda et al. Heart Asia 2013;5:7-14
Baseline Characteristics by Tertiles of Homocysteine
Diet is the worst of the risk issues in the USA
Diet is the worst of the risk issues in the USA
William S. Jenkins, MB, BCh, Véronique L. Roger, MD, MPH, Allan S
Determinants of moderate Cardiovascular Health Index Score (achieving three or more risk factor targets), stratified by region conventions as in figure.
Proportions of the social isolation—AMI and stroke excess risk mediated by biological, behavioural, socioeconomic and health-related factors. Proportions.
Comparison of heart failure admissions rates per annum (recorded hospital admissions/ population at risk) in western developed countries 1978 to.
Jenna Barton, MSN, RN-C, PCCN
The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.
Presentation transcript:

Plasma Free Fatty Acids and Risk of Heart FailureClinical Perspective by Luc Djoussé, David Benkeser, Alice Arnold, Jorge R. Kizer, Susan J. Zieman, Rozenn N. Lemaitre, Russell P. Tracy, John S. Gottdiener, Dariush Mozaffarian, David S. Siscovick, Kenneth J. Mukamal, and Joachim H. Ix Circ Heart Fail Volume 6(5):964-969 September 17, 2013 Copyright © American Heart Association, Inc. All rights reserved.

Cumulative incidence of heart failure according to tertiles of free fatty acids during follow-up in the Cardiovascular Health Study. Cumulative incidence of heart failure according to tertiles of free fatty acids during follow-up in the Cardiovascular Health Study. Luc Djoussé et al. Circ Heart Fail. 2013;6:964-969 Copyright © American Heart Association, Inc. All rights reserved.